Investor Oliveira Steven Michael
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Oliveira Steven Michael . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-04-16 13G ATHA / Athira Pharma, Inc. 1,994,649
2025-01-10 13G FBRX / Forte Biosciences, Inc. 0 432,276
2024-04-29 13G BLT / BENITEC BIOPHARMA INC 98,203 791,235
2023-08-18 13G/A BLT / BENITEC BIOPHARMA INC 2,084,171 98,203
2022-10-07 13G/A BNTC / Benitec Biopharma Inc. 668,123 2,084,171
2022-05-09 13G/A IGNY / Ignyte Acquisition Corp 400,000 0
2022-03-09 13G TRVI / Trevi Therapeutics, Inc. 1,340,000
2022-03-02 13G/A LBPS / 4d Pharma Plc - ADR 5,905,552 5,905,552
2022-02-03 13G/A LBPS / 4d Pharma Plc - ADR 20,883,426 5,905,552
2022-01-19 13G/A CHAQ / Chardan Healthcare Acquisition 2 Corp 575,000
2021-09-21 13G/A FBRX / Forte Biosciences, Inc. 651,067 0
2021-04-14 13G/A BNTC / Benitec Biopharma Inc. 395,084 668,123
2021-04-12 13G LBPS / 4d Pharma Plc - ADR 20,883,426
2021-04-05 13G BNTC / Benitec Biopharma Inc. 395,084
2021-02-16 13G/A FBRX / Forte Biosciences, Inc. 561,067 651,067
2021-02-16 13G/A VGG563721163 / Longevity Acquisition Corp 175,186 212,479
2021-02-16 13G/A PLBY / Playboy, Inc. 650,000 0
2021-02-02 13G IGNY / Ignyte Acquisition Corp 400,000
2020-10-27 13G VGG563721163 / Longevity Acquisition Corp 175,186
2020-09-01 13G FBRX / Forte Biosciences, Inc. 4,000,000 561,067
2020-06-11 13G PLBY / Playboy, Inc. 650,000
2020-02-28 13G FBRX / Forte Biosciences, Inc. 4,000,000
2013-09-27 13D/A IDEX / Ideanomics, Inc. 698,980
2012-12-27 13G/A 76028H209 / Repros Therapeutics, Inc. 741,100